SCHEMBL10012229

SCHEMBL10012229

N#CCCCOC(=O)CCCCCCC(=O)OCCCC#N

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.50
DNM1 Q05193 1/20 0.42
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
MAPT P10636 1/20 0.39
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
PAM P19021 2/20 0.37
KDM4E B2RXH2 1/20 0.37
DUSP3 P51452 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR2C P28335 1/20 0.37
NAAA Q02083 1/20 0.36
P2RY10 O00398 3/20 0.35
GPR34 Q9UPC5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10011990 0.98 DGKA (0.47) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10010745 0.96 DGKA (0.45) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10010268 0.94 DGKA (0.48) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10012228 0.94 DGKA (0.48) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10011654 0.94 DGKA (0.42) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10012231 0.93 DGKA (0.44) DGKADNM1MAPTLMNAALDH1A1
SCHEMBL10010324 0.92 DGKA (0.45) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10010832 0.92 DGKA (0.45) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10010434 0.91 ADRA2A (0.41) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL10012894 0.90 DGKA (0.41) DGKAMAPTLMNAALDH1A1PAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 DGKA 1127/4885DNM1 1930/4885PRSS1 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.